The breathless hype around AI saving healthcare is crashing into reality. According to a new analysis, 2026 is the year AI tools must prove they actually help clinicians, or get left behind. The focus is shifting back to the human at the center of care.
The healthcare industry is undergoing a consumer-driven transformation. Patients want the same personalized, convenient experiences they get from retail and banking, and AI is becoming the key to meeting these expectations.
Scientists have developed an AI tool that can identify structural heart damage using simple smartwatch ECG data. The breakthrough could enable large-scale screening for conditions previously requiring hospital equipment.
A groundbreaking $1 billion partnership between the Department of Energy and AMD aims to build AI supercomputers that could revolutionize cancer treatment. But experts warn the real challenge isn’t computing power—it’s data access and integration.
Revolutionizing Glioblastoma Treatment with Localized Immunotherapy Glioblastoma (GBM) remains one of the most challenging cancers to treat, with recurrence rates…
Revolutionary Approach to Understanding Drug Resistance in Blood Cancers In a groundbreaking study published in Nature Biomedical Engineering, researchers have…
A groundbreaking approach to polymer design focusing on water mobility has yielded significant improvements in blood compatibility for medical devices. The technology has already demonstrated clinical benefits in artificial kidneys and shows promise for broader medical applications.
Researchers have developed a novel approach to creating antithrombogenic polymers that significantly improves blood compatibility in medical devices, according to recent reports in the Polymer Journal. Rather than focusing solely on increasing hydrophilicity as traditionally done, scientists reportedly targeted the mobility of water molecules surrounding both polymers and proteins, leading to breakthrough improvements in artificial kidney technology and other medical applications.
Robotic Surgery Pioneer Exceeds Financial Expectations Intuitive Surgical, the global leader in robotic-assisted minimally invasive surgery, has delivered impressive third-quarter…
Scientists have identified TLK2 as a critical regulator of chromatin loop formation influencing cancer stem cell plasticity. The findings suggest targeting chromatin architecture could provide new avenues for combating treatment-resistant cancers. This discovery opens potential pathways for disrupting cancer stemness mechanisms.
Researchers have uncovered a previously unknown mechanism controlling cancer stem cell plasticity through chromatin loop regulation, according to a recent study published in Nature Communications. The report states that the protein TLK2 plays a crucial role in forming CTCF-cohesin hubs that maintain chromatin architecture, potentially influencing how cancer cells adapt and resist treatments.
The Endometriosis Diagnostic Revolution For decades, endometriosis diagnosis has relied on invasive laparoscopic surgery, creating significant barriers to timely treatment.…
